5:46 PM
Apr 02, 2014
 |  BC Extra  |  Financial News

Exact Sciences planning $125 million follow-on

Diagnostic company Exact Sciences Corp. (NASDAQ:EXAS) proposed late Wednesday to raise $125 million in a follow-on underwritten by Jefferies; Goldman Sachs; Baird;...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >